Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,736,261 papers from all fields of science
Search
Sign In
Create Free Account
octreotide pamoate
Known as:
OP LAR
, Octreotide Embpnate
, Octreotide Pamoate LAR(SMS 201-995)
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Octreotide
Positive Regulation of Apoptosis
Receptor Activation Process
Somatostatin Receptor
Narrower (2)
OncoLar
SMS 201-995 pa LAR
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and β-Arrestin2 with Antinociceptive Activity
Pingwei Zhao
,
Haleli Sharir
,
+13 authors
M. Abood
Molecular Pharmacology
2010
Corpus ID: 22802363
Known agonists of the orphan receptor GPR35 are kynurenic acid, zaprinast, 5-nitro-2-(3-phenylproplyamino) benzoic acid, and…
Expand
2005
2005
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.
S. Helle
,
W. Mietlowski
,
+11 authors
P. Lønning
European journal of cancer
2005
Corpus ID: 22818750
Highly Cited
2004
Highly Cited
2004
High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours.
S. Welin
,
E. T. Janson
,
+6 authors
B. Eriksson
European journal of endocrinology
2004
Corpus ID: 7317329
OBJECTIVE High-dose somatostatin analogue treatment has shown an antiproliferative effect in one study including patients with…
Expand
Highly Cited
2002
Highly Cited
2002
A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth…
C. Khanna
,
J. Prehn
,
+7 authors
L. Helman
Clinical cancer research : an official journal of…
2002
Corpus ID: 10714776
PURPOSE The purpose of this research was to determine whether insulin-like growth factor (IGF) suppression, using a long-acting…
Expand
2002
2002
A randomized, multicenter prospective trial assessing long‐acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma
E. Bajetta
,
G. Procopio
,
+7 authors
R. Buzzoni
Cancer
2002
Corpus ID: 20719076
Long‐acting release octreotide pamoate (OP‐LAR) is a synthetic octapeptide that can be administered monthly and whose activity is…
Expand
2002
2002
The NCIC CTG MA.14 experience with the gallbladder toxicity of octreotide pamoate (oncolar) in a postmenopausal patient population undergoing adjuvant treatment for stage 1-3 breast cancer
M. Pollak
2002
Corpus ID: 72830844
2002
2002
Adding long-acting release octreotide pamoate to tamoxifen does not improve tumor response in advanced breast cancer
H. Sommer
,
W. Janni
2002
Corpus ID: 72722977
1998
1998
Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.
S. Helle
,
J. Geisler
,
+6 authors
P. Lønning
British Journal of Cancer
1998
Corpus ID: 1979422
Fourteen patients suffering from advanced colorectal (n = 7), pancreatic (n = 4) or gastric (n = 3) carcinomas received treatment…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE